Skip to main content

Table 1 Patient characteristics

From: Whole-liver radiotherapy for end-stage colorectal cancer patients with massive liver metastases and advanced hepatic dysfunction

Patient No.

Age (yr)

Gender

Primary tumor site

Initial stage

Surgical resection

Extrahepatic metastasis at initial diagnosis

Interval from liver metastasis to RT (mo)

Extrahepatic metastasis at the time of RT

Serum CEA* before RT (ng/mL)

Child-Pugh classification before RT

     

Primary

Liver

     

1

47

F

Rectum

pT3N0M1

Y

N

Y

30

Y

1727

B

2

57

M

Colon

pT3N0M1

Y

Y

Y

18

Y

1481

C

3

53

F

Colon

pT4N1M1

Y

N

Y

18

Y

11858

B

4

42

F

Rectum

pT3N2M1

Y

Y

Y

13

Y

5198

B

5

61

F

Colon

pT4N2M1

Y

N

N

4

N

7629

B

6

68

F

Colon

cT3N2M1

N

N

Y

6

Y

10

C

7

45

F

Colon

pT3N2M1

Y

N

N

26

Y

2103

B

8

57

F

Colon

pT3N2M1

Y

N

Y

11

Y

373

B

9

70

F

Colon

pT3N0M1

Y

N

Y

11

Y

6424

B

10

73

F

Rectum

cT3N2M1

N

N

Y

8

Y

4092

B

  1. *Carcinoembryonic antigen (normal range, ≤ 5 ng/mL)
  2. Measured 3 months before RT. Levels in other patients were assessed 1 month before RT